A Dark Vector Cognition product

Item 6. Selected Financial Data

10K characters. Original on sec.gov · Markdown

Item 6. Selected Financial Data

We have derived the following consolidated statement of income data for 2015, 2014 and 2013 and consolidated balance sheet data as of December 31, 2015 and 2014 from our audited consolidated financial statements included elsewhere in this Annual Report on Form 10-K. We have derived the following consolidated statement of income data for 2012 and 2011 and consolidated balance sheet data as of December 31, 2013, 2012 and 2011 from our audited consolidated financial statements not included in this Annual Report on Form 10-K. You should read the consolidated financial data set forth below in conjunction with our consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K and the information under Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Our historical results are not necessarily indicative of the results we may achieve in any future period.

Year Ended December 31,
20152014201320122011
(in thousands, except per share data)
Statement of Income Data:
Service revenues$4,326,419$4,165,822$3,808,340$3,692,298$3,294,966
Reimbursed expenses1,411,2001,294,1761,291,2051,173,2151,032,782
Total revenues5,737,6195,459,9985,099,5454,865,5134,327,748
Costs of revenue, service costs2,725,5862,684,1062,471,4262,459,3672,153,005
Costs of revenue, reimbursed expenses1,411,2001,294,1761,291,2051,173,2151,032,782
Selling, general and administrative920,985882,338860,510817,755762,299
Restructuring costs30,7528,98814,07118,74122,116
Impairment charges (1)2,484———12,295
Income from operations646,612590,390462,333396,435345,251
Interest expense, net97,47597,179119,571131,304105,126
Loss on extinguishment of debt7,780—19,8311,27546,377
Other expense (income), net2,362(8,978)(185)(3,572)9,073
Income before income taxes and equity in earnings (losses) of unconsolidated affiliates538,995502,189323,116267,428184,675
Income tax expense158,989150,05695,96593,36415,105
Income before equity in earnings (losses) of unconsolidated affiliates380,006352,133227,151174,064169,570
Equity in earnings (losses) of unconsolidated affiliates (2)8,2984,368(1,124)2,56770,757
Net income388,304356,501226,027176,631240,327
Net (income) loss attributable to noncontrolling interests(1,099)(118)5649151,445
Net income attributable to Quintiles Transnational Holdings Inc.$387,205$356,383$226,591$177,546$241,772
Earnings per share attributable to common shareholders:
Basic$3.15$2.78$1.83$1.53$2.08
Diluted$3.08$2.72$1.77$1.51$2.05
Cash dividends declared per common share$—$—$—$4.91$2.48
Weighted average common shares outstanding:
Basic123,038127,994124,147115,710116,232
Diluted125,630131,083127,862117,796117,936
Year Ended December 31,
20152014201320122011
(in thousands)
Statement of Cash Flow Data:
Net cash provided by (used in):
Operating activities$475,691$431,754$393,371$335,701$160,953
Investing activities(66,955)(173,114)(236,176)(132,233)(224,838)
Financing activities(249,246)(130,344)70,957(146,873)(59,309)
Other Financial Data:
Capital expenditures$(78,391)$(82,650)$(88,347)$(71,336)$(75,679)
Cash dividend paid to common shareholders———(567,851)(288,322)
Net new business (unaudited) (3)5,318,8005,602,4004,898,9004,501,2004,044,100
As of December 31,
20152014201320122011
(in thousands)
Balance Sheet Data:
Cash and cash equivalents$977,151$867,358$778,143$567,728$516,299
Investments in debt, equity and other securities32,91134,50340,34935,95122,106
Trade accounts receivable and unbilled services, net1,165,749975,255924,205745,373691,038
Property and equipment, net188,393190,297199,578193,999185,772
Total assets3,926,3163,295,9533,054,2232,475,5322,304,486
Total long-term liabilities2,667,8212,528,0652,239,4612,525,5792,091,448
Total debt and capital leases (4)2,500,7812,305,6962,060,9942,444,8861,990,196
Total shareholders' deficit(335,681)(704,012)(667,485)(1,359,044)(969,596)
Other Financial Data:
Backlog (unaudited) (3)$12,038,000$11,244,400$9,855,400$8,704,500$7,972,900
(1)In 2015 and 2011, we wrote down $2.5 million and $12.2 million, respectively, related to long-lived assets, and in 2011 we incurred other than temporary losses of $145,000 related to a non-marketable equity security.
(2)In November 2011, we sold our investment in Invida Pharmaceutical Holdings Pte. Ltd. for approximately $103.6 million of net proceeds resulting in a gain of approximately $74.9 million.
(3)Net new business is the value of services awarded during the period from projects under signed contracts, letters of intent and, in some cases, pre-contract commitments that are supported by written communications, adjusted for contracts that were modified or canceled during the period. Consistent with our methodology for calculating net new business during a particular period, backlog represents, at a particular point in time, future service revenues from work not yet completed or performed under signed contracts, letters of intent and, in some cases, pre-contract commitments that are supported by written communications. Historically, net new business and backlog denominated in foreign currencies were valued each month throughout the year using foreign exchange rates that were in effect at the beginning of each fiscal year. Beginning with the first quarter of 2015, net new business and backlog denominated in foreign currencies are valued each month using the actual average foreign exchange rates in effect during the month. The application of this new approach to value foreign currency denominated net new business and backlog would not have had a significant impact to any prior period’s reported amounts, therefore historical amounts have not been restated to reflect this change in methodology.
(4)Excludes $33.0 million, $22.3 million, $27.5 million, $46.5 million and $36.8 million of unamortized discounts and debt issuance costs as of December 31, 2015, 2014, 2013, 2012 and 2011, respectively.

Previous: Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities · Next: Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations